JIANGBO PHARMACEUTCL (NASDAQ:JGBO)

Wednesday, May 25, 2011 | Web News
First Quarter Results: Revenue decreased 29.2% to $18.1 million from $25.6 million in the corresponding quarter ended...
Monday, May 16, 2011 | Web News
LAIYANG, China, May 16, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. today announced the appointment of Ms. Ziling...
Monday, April 18, 2011 | Web News
LAIYANG, China, April 18, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. today announced that Laiyang Jiangbo Pharmaceutical Co.,...
See All Research...

At least one VIE exists in the corporate structure

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form.

Reverse Merger Filing

Web site: http://www.genesispharmaceuticals.com/

Last updated May 19, 2009